Kurevija, T.; Šojat, D.; Bosnić, Z.; Mujaj, B.; Canecki Varžić, S.; Majnarić Trtica, L.
The Reasons for the Low Uptake of New Antidiabetic Drugs with Cardiovascular Effects—A Family Doctor Perspective. J. Clin. Med. 2024, 13, 1617.
https://doi.org/10.3390/jcm13061617
AMA Style
Kurevija T, Šojat D, Bosnić Z, Mujaj B, Canecki Varžić S, Majnarić Trtica L.
The Reasons for the Low Uptake of New Antidiabetic Drugs with Cardiovascular Effects—A Family Doctor Perspective. Journal of Clinical Medicine. 2024; 13(6):1617.
https://doi.org/10.3390/jcm13061617
Chicago/Turabian Style
Kurevija, Tomislav, Dunja Šojat, Zvonimir Bosnić, Blerim Mujaj, Silvija Canecki Varžić, and Ljiljana Majnarić Trtica.
2024. "The Reasons for the Low Uptake of New Antidiabetic Drugs with Cardiovascular Effects—A Family Doctor Perspective" Journal of Clinical Medicine 13, no. 6: 1617.
https://doi.org/10.3390/jcm13061617
APA Style
Kurevija, T., Šojat, D., Bosnić, Z., Mujaj, B., Canecki Varžić, S., & Majnarić Trtica, L.
(2024). The Reasons for the Low Uptake of New Antidiabetic Drugs with Cardiovascular Effects—A Family Doctor Perspective. Journal of Clinical Medicine, 13(6), 1617.
https://doi.org/10.3390/jcm13061617